Open randomized intergroup trial about efficacy and the safety of minodronate raloxifene and eldecalcitol in the drug choice after teriparatide 24 months administration for osteoporosis.

Trial Profile

Open randomized intergroup trial about efficacy and the safety of minodronate raloxifene and eldecalcitol in the drug choice after teriparatide 24 months administration for osteoporosis.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Oct 2016

At a glance

  • Drugs Minodronic acid (Primary) ; Eldecalcitol; Raloxifene
  • Indications Postmenopausal osteoporosis
  • Focus Adverse reactions; Biomarker; Therapeutic Use
  • Most Recent Events

    • 10 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top